Author
Listed:
- Uthman Ademola Yusuf
(Mulungushi University, Zambia)
- Wana Iputu
(Mulungushi University, Zambia)
- Musonda Kambele
(Mulungushi University, Zambia)
- Mpeza Kalowa
(Mulungushi University, Zambia)
- Michelo Miyoba
(Mulungushi University, Zambia)
- Isabel Namfukwe Luambia
(Mulungushi University, Zambia)
- Precious Simushi
(Livingstone Central Hospital Laboratory, Zambia)
- Aminat Adejoke Yusuf
(Ladoke Akintola University of Technology, Nigeria)
- Memory Ngosa
(Mulungushi University, Zambia)
Abstract
The cactus plant is one of the most common plants used in treatment all kinds of ailment. Studies have shown that the cactus extract has both antihyperglycemic and neuroprotective effects. This research will focus on some of the effect of an aqueous extract of cactus on the cytoarchitecture of the frontal cortex of the diabetic Wistar rats. Thirty (30) male Wistar rats were randomly selected and placed into five (5) groups of 6 Wistar rats each. These include the control group A, diabetic only group B, diabetic+cactus group C, diabetic+metformin group D, and cactus only group E. The animals were acclimatized for one week. The Rats were weighed, and a baseline glucose level established after the overnight fasting period. The animals were injected with streptozotocin calculated at a dose of 70 mg/kg body weight and reintroduced to the normal feeding cycle. After about 72 hours, diabetes was established (blood glucose≥ 7 mmol). The administration of Cactus extract of 100 mg/kg BW and Metformin of 100 mg/kg BW commenced for four weeks. After fourth week the animals were sacrificed by euthanasia and the brain was harvested and fixed in 10 % formal saline for H and E and PTAH staining. At the end of the four weeks experiments the results shows, the average body weight of the rats in the diabetic+cactus group showed an increase by the end of the four-week experiment which was not significantly different to the normal control group, while the diabetic+metformin group was significantly different to the control group and also diabetic control group was significant to normal control group. The relative brain weight of the diabetic+cactus and diabetic+metformin group were not significantly different to the normal control (p>0.05). The blood glucose levels of the diabetic+cactus and diabetic+metformin group at the end of the fourth week were not significant different from Group A (p>0.05). The H and E photomicrographs of diabetic group show that most cells were necrotic, and the normal pyramidal cells present were scanty. The diabetic+cactus group showed presence of more normal pyramidal cells than necrotic cells. The diabetic+metformin group showed presence of both normal and necrotic pyramidal cells. The PTAH staining in the diabetic group, there were astrocytes present with degenerated neuron. Diabetic+cactus and diabetic+metformin groups showed some neurons were degenerated while some appeared normal with astrocytes while the cytoarchitecture of cactus only group are similar to that of normal control group. Aqueous extract of cactus possesses anti hyperglycemic effects and can be a potential and effective therapy for the management of diabetes due to its ameliorative properties as shown in the findings of this research.
Suggested Citation
Handle:
RePEc:epw:pharma:v:3:y:2023:i:2:id:761
DOI: 10.24018/ejpharma.2023.3.2.61
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:pharma:v:3:y:2023:i:2:id:761. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support Team (email available below). General contact details of provider: https://eu-opensci.org/index.php/pharma .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.